International trade · 29/11/2006

U.S. International Trade Commission to Review Final Initial Determination for Modified Vaccinia Ankara Viruses and Vaccines

The U.S. International Trade Commission has decided to review its entire final initial determination for the investigation into modified Vaccinia Ankara viruses and vaccines, and has extended the deadline for completing the investigation, which will now focus on briefing on issues related to review, remedy, and public interest, with a new target completion date.